Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience.

Neurological research and practice·2026
Same author

Collaborative neurocardiology board meetings for decision-making in stroke care: a real-world experience.

Neurological research and practice·2026
Same author

Editorial: Current proceedings in magnetocardiology-past, present, future.

Frontiers in cardiovascular medicine·2024
Same author

Magnetocardiography at rest predicts cardiac death in patients with acute chest pain.

Frontiers in cardiovascular medicine·2023
Same author

Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI).

Clinical research in cardiology : official journal of the German Cardiac Society·2023
Same author

High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany.

Clinical research in cardiology : official journal of the German Cardiac Society·2023

Related Experiment Video

Updated: May 1, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

8.4K

Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic

U Landmesser1, B Hornig, H Drexler

  • 1Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Germany.

Seminars in Thrombosis and Hemostasis
|December 29, 2000
PubMed
Summary

Endothelial dysfunction in hypercholesterolemia impairs nitric oxide (NO) bioavailability, contributing to vascular disease. Cholesterol-lowering treatments can reverse this dysfunction and may even regress atherosclerotic lesions.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.6K

Related Experiment Videos

Last Updated: May 1, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

8.4K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.6K

Area of Science:

  • Vascular Biology
  • Cardiovascular Research
  • Endothelial Function

Background:

  • The endothelium plays a crucial role in vascular health, regulating vasodilation, leukocyte adhesion, and platelet aggregation.
  • Nitric oxide (NO), synthesized by endothelial NO synthase, is a key mediator of many endothelial functions.
  • Endothelial dysfunction, characterized by reduced NO bioavailability, is a hallmark of hypercholesterolemia and contributes to vascular disease.

Purpose of the Study:

  • To investigate the mechanisms of endothelial dysfunction in hypercholesterolemia.
  • To explore the functional implications of endothelial dysfunction in cardiovascular disease.
  • To evaluate the reversibility of endothelial dysfunction and its impact on atherosclerosis.

Main Methods:

  • Review of existing literature on endothelial function and hypercholesterolemia.
  • Analysis of factors contributing to reduced NO bioavailability in hypercholesterolemic patients.
  • Examination of studies on cholesterol-lowering treatments and their effects on endothelial function and atherosclerosis.

Main Results:

  • Reduced NO bioavailability in hypercholesterolemia results from increased NO inactivation by radicals and inhibited NO formation.
  • Endothelial dysfunction is linked to myocardial perfusion abnormalities and plays a role in atherosclerosis development and progression.
  • Cholesterol-lowering therapy, specifically with HMG-CoA-reductase inhibitors, reverses endothelial dysfunction in hypercholesterolemia.

Conclusions:

  • Endothelial dysfunction is a significant contributor to vascular disease in hypercholesterolemia, primarily due to impaired NO bioavailability.
  • Therapeutic strategies aimed at increasing NO bioavailability may offer a promising approach to managing atherosclerosis.
  • Reversal of endothelial dysfunction and potential regression of atherosclerotic lesions are achievable with cholesterol-lowering treatments.